scholarly journals Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

Blood ◽  
2014 ◽  
Vol 123 (5) ◽  
pp. 678-686 ◽  
Author(s):  
Holbrook E. Kohrt ◽  
Ariane Thielens ◽  
Aurelien Marabelle ◽  
Idit Sagiv-Barfi ◽  
Caroline Sola ◽  
...  

Key Points Blockade of inhibitory KIRs with MHC class I antigens on lymphoma cells by anti-KIR antibodies augments NK-cell spontaneous cytotoxicity. In combination with anti-CD20 mAbs, anti-KIR induces enhanced NK cell–mediated, rituximab-dependent cytotoxicity against lymphoma.

1997 ◽  
Vol 175 (2) ◽  
pp. 171-178 ◽  
Author(s):  
Caroline E. Donnelly ◽  
Christopher Yatko ◽  
Eric W. Johnson ◽  
Albert S.B. Edge

1995 ◽  
Vol 42 (1) ◽  
pp. 34-38 ◽  
Author(s):  
M. G. E. PETERSSON ◽  
A. GRONBERG ◽  
R. KIESSLING ◽  
M. T. FERM

2005 ◽  
Vol 11 (20) ◽  
pp. 7516-7522 ◽  
Author(s):  
Claire Germain ◽  
Christel Larbouret ◽  
Valérie Cesson ◽  
Alena Donda ◽  
Werner Held ◽  
...  

2016 ◽  
Vol 1 (3) ◽  
pp. 208-218 ◽  
Author(s):  
Rachel J. Bergerson ◽  
Robin Williams ◽  
Hongbo Wang ◽  
Ryan Shanley ◽  
Gretchen Colbenson ◽  
...  

Key Points Low numbers of reconstituting NK cells at D+28 after dUCBT are associated with inferior DFS. Patients with low NK cell numbers at D+28 have reduced phosphorylation of STAT5 upon IL-15 stimulation and less Eomes expression.


2020 ◽  
Vol 8 (6) ◽  
pp. 756-768 ◽  
Author(s):  
Nana Dang ◽  
Yuan Lin ◽  
Mark Waer ◽  
Ben Sprangers

2014 ◽  
Vol 5 ◽  
Author(s):  
Stéphanie Bessoles ◽  
Camille Grandclément ◽  
Elisenda Alari-Pahissa ◽  
Jasmine Gehrig ◽  
Beena Jeevan-Raj ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document